Literature DB >> 24094552

Optimal serum phenylalanine for adult patients with phenylketonuria.

Yoshiyuki Okano1, Hironori Nagasaka.   

Abstract

High serum phenylalanine in adult patients with phenylketonuria (PKU) causes neuropsychological and psychosocial problems that can be resolved by phenylalanine-restricted diet. Therefore, PKU patients must continue to adhere to phenylalanine-restricted diet for life, although the optimal serum phenylalanine level in later life has yet to be established. The purpose of this review was to establish the optimal serum phenylalanine level in later life of PKU patients. We evaluated oxidative stress status, nitric oxide metabolism, cholesterol-derived oxysterols, vitamin D and bone status, and magnetic resonance imaging (MRI) in adult PKU patients according to serum phenylalanine level. Oxidative stress increased markedly at serum phenylalanine of 700-800 μmol/L. Serum phenylalanine higher than 700-850 μmol/L correlated with the disturbance of nitric oxide regulatory system. Adult PKU patients had poor vitamin D status and exhibited predominance of bone resorption over bone formation. In the brain, the levels of 24S-hydroxycholesterol, a marker of brain cholesterol elimination, were low at serum phenylalanine levels exceeding 650 μmol/L. MRI studies showed high signal intensity in deep white matter on T2-weighted and FLAIR images of PKU patients with serum phenylalanine greater than 500 μmol/L, with decreased apparent diffusion coefficients. Changes in most parameters covering the entire body organs in adult PKU were almost acceptable below 700-800 μmol/L of phenylalanine level. However, the optimal serum phenylalanine level should be 500 μmol/L or less in later life for the brain to be safe.
© 2013.

Entities:  

Keywords:  ADCs; ADMA; GPx; LDL; MDA-LDL; MRI; Magnetic resonance imaging; NO; NOx; Nitric oxide; OH cholesterol; Oxidative stress; Oxysterol; PKU; Phenylalanine; Phenylketonuria; SOD; TAR; TBARS; apparent diffusion coefficients; asymmetric dimethylarginine; glutathione peroxidase; hydroxycholesterol; low-density lipoprotein; magnetic resonance imaging; malondialdehyde-modified low-density lipoprotein; nitrate/nitrite as stable metabolites of nitric oxide; nitric oxide; phenylketonuria; superoxide-dismutase; thiobarbituric acid-reactive species; total antioxidant reactivity

Mesh:

Substances:

Year:  2013        PMID: 24094552     DOI: 10.1016/j.ymgme.2013.09.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

Authors:  P Burgard; E Mönch; J Zschocke; U Wendel; U Langenbeck
Journal:  JIMD Rep       Date:  2015-12-19

2.  Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.

Authors:  Fatemeh Keshavarzi; Mohsen Rastegar; Mahmood Vessal; Gholamreza Rafiei Dehbidi; Marjan Khorsand; Amir Hossein Ganjkarimi; Mohammad Ali Takhshid
Journal:  Metab Brain Dis       Date:  2017-12-21       Impact factor: 3.584

3.  Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

Authors:  Bridget M Stroup; Nivedita Nair; Sangita G Murali; Katarzyna Broniowska; Fran Rohr; Harvey L Levy; Denise M Ney
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

4.  Metabolome-wide association study of phenylalanine in plasma of common marmosets.

Authors:  Young-Mi Go; Douglas I Walker; Quinlyn A Soltow; Karan Uppal; Lynn M Wachtman; Fredrick H Strobel; Kurt Pennell; Daniel E L Promislow; Dean P Jones
Journal:  Amino Acids       Date:  2014-12-21       Impact factor: 3.520

5.  Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Authors:  Charlotte Veyrat-Durebex; Christelle Debeissat; Hélène Blasco; Franck Patin; Hélène Henique; Patrick Emond; Catherine Antar; Valérie Gissot; Olivier Herault; François Maillot
Journal:  JIMD Rep       Date:  2017-03-15

6.  Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.

Authors:  T Mlčoch; R Puda; P Ješina; M Lhotáková; Š Štěrbová; T Doležal
Journal:  Eur J Clin Nutr       Date:  2017-06-28       Impact factor: 4.016

7.  Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China.

Authors:  Jinhua Gong; Lina He; Qinyuan Zou; Yangyang Zhao; Bangzhou Zhang; Rongmu Xia; Baolong Chen; Man Cao; Wenxiu Gong; Lin Lin; Xiujuan Lin; Guowei Wang; Muyun Guo; Jianquan He; Chuanxing Xiao; Jian Chen
Journal:  Microb Cell Fact       Date:  2022-07-11       Impact factor: 6.352

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.

Authors:  María L Couce; Isidro Vitoria; Luís Aldámiz-Echevarría; Ana Fernández-Marmiesse; Iria Roca; Marta Llarena; Paula Sánchez-Pintos; Rosaura Leis; Alvaro Hermida
Journal:  Orphanet J Rare Dis       Date:  2016-09-09       Impact factor: 4.123

10.  Arterial stiffness assessment in patients with phenylketonuria.

Authors:  Alvaro Hermida-Ameijeiras; Vanesa Crujeiras; Iria Roca; Carlos Calvo; Rosaura Leis; María-Luz Couce
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.